**Abstract**

**Objectives:** Amongst sexually active young adults, a notable number struggle to control this behavior, resulting in significant impairment and distress. Previous assessments of problematic sexual behavior (PSB) have noted select clinical and neurocognitive differences relative to other patient populations and healthy controls, but neurocognitive findings have varied. This analysis assesses the clinical presentation and neurocognitive profile of patients with PSB relative to those with no sexual problems.

**Methods:** 492 participants (18--29) were recruited for a study on impulsivity in young adults. Participants completed diagnostic, self-report, and neurocognitive measures which assessed impulsivity, cognitive flexibility, decision making, and spatial working memory. PSB was defined as endorsing fantasies, urges, or sexual behavior that felt out of control or was causing distress.

**Summary:** 54 (11%) participants reported current PSB. This group was older, reported earlier first sexual experiences and earlier alcohol use, and lower quality of life and self-esteem. Comorbidity rates were higher in the PSB group, particularly for depression and alcohol dependence. The PSB group differed across cognitive measures related to impulsivity, decision making, spatial working memory, problem solving, and emotional dysregulation.

**Conclusions:** These findings suggest that PSB is associated with numerous problems, including psychosocial dysfunction, higher comorbidity rates, and deficits in several neurocognitive domains. These associations appear to extend beyond those directly related to sex or sexual health, suggesting a more salient impact on wellbeing and functioning. Furthermore, this study demonstrated several neurocognitive deficits in the PSB group, features which have found only mixed support in previous studies. These cognitive differences may be particularly notable for clinicians treating patients with PSB, as it may be possible to tailor treatment options to address these unique features of PSB relative to other patient populations.
